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Abstract
A rare case of Acute lymphoblastic leukemia with hemophillia in a 12 year old boy is presented in
the article. Patient was known case of hemophillia (factor VIII deficiency). He was diagnosed as a
case of ALL based on bone marrow examination and immunophenotypic study. Patient was treated
as per Children Cancer group guidelines. The main aim of reporting this rare association lies in
developing treatment strategies in preventing life threatening bleeding due to this rare association
which though may be accidental but need further research.
Introduction
Acute lympphoblastic leukaemia accounts for around
77% of childhood leukemia. Hemophilia is a congenital
bleeding disorder characterized by deficiency of coagula-
tion factor VIII or IX out of which 85% is due to factor VIII
deficiency and 15% due to factor IX deficiency. The coin-
cidence of these two diseases together is rare which has led
to challenges in developing treatment strategies.
Case Report
12 yr old boy known case of hemophilia (factor VIII defi-
ciency) diagnosed at 6 month of age presented with inter-
mittent fever (on and off) of 2 month without chills and
rigors, significant weight loss of 3 kilograms in 1 one
month, generalized weakness of 1 month and joint swell-
ing right knee of 7 days duration. The swelling was spon-
taneous associated with restriction of movements. There
was no family history of malignancy or bleeding disor-
ders.
On examination, the anthropometric measurements were
appropriate for age. There was pallor, petechiae and
ecchymoses on his legs, along with gingival bleeding, and
haematoma on right knee. Systemic examination revealed
hepatosplenomegaly. Peripheral blood counts revealed
hemoglobin levels of 7.6 g%, white cell counts of 41 ×
109/L (blasts 85%), and platelet counts of 100 × 109/L.
After receiving 40 U/kg FVIII concentrates, bone marrow
aspiration was performed, which showed lymphoblast of
85%. His immunophenotype consisted of CD3 87%,
CD7 99%, CD8 10%, CD5 3%, CD10 98%, CD19 18%,
CD22 20% and HLA DR negative The cells were negative
with MPO staining. RT-PCR for BCR abl negative. A hepa-
titis viruses screening test found the patient to be hepatitis
B and C negative. HIV serological test was negative and
cytogenetic test revealed 46, XY. Coagulation screening
showed a prolonged activated partial thromboplastin
time (APTT) (test 46 seconds, control 28 seconds), with
normal prothrombin time. The ultrasound scan of abdo-
men revealed hepatosplenomegaly, Echocardiography
and Xray chest was normal.
After admission to our center, the patient received 30 U/
kg of factor VIII. The swelling and pain in his right knee
subsided. The patient was placed on induction therapy on
the second day, which included oral prednisolone,
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intrathecal methotrexate, vincristine, daunorubicin. There
was no CNS involvement. He was given treatment as per
CCG guidelines(Children Cancer Group) which includes
4 weeks of induction, 8 weeks of consolidation, 8 weeks
of interim maintenance cycle I (8 weeks), delayed intensi-
fication I (8 weeks), delayed intensification II (8 weeks)
and maintenance period of 12 weeks. The patient was
given intrathecal methotrexate under the cover of factor
VIII. During the induction phase there was period of
febrile neutropenia, thrombocytopenia and swelling of
right knee joint which was managed with antibiotics,
platelet transfusion and factor VIII. His peripheral blood
counts gradually returned to normal during the treatment,
and the patient did not have bleeding complications sub-
sequently. After twenty-eight days of treatment, the
patient achieved complete remission. The bone marrow
done revealed blasts cells of less than 5% which was con-
sistent with remission. He was discharged from the hospi-
tal on the 31st day of induction therapy. He has remained
in good condition since then.
Discussion
In literature, 11 cases of hemophilia with acute leukemia
have been documented [1-5] with only 5 pediatric
patients. Other authors have reported an increased risk of
lymphoma in hemophilia patients, mainly among HIV
positive patients [6,7]. Further it has also been observed
that hemophiliac patients have long-term abnormalities
of immune function from factor concentrate usage [8-10].
Thus, probable factor contributing to a high risk of lym-
phocytic malignancy could be immunological dysfunc-
tion caused by factor concentrate use and/or HIV.
However, as of now, only 5 hemophilia patients with
acute non-lymphocytic leukemia have been described. It
is likely that the association of these two disorders is
merely accidental, although further confirmation is
needed to bring about more facts under the scanner.
The coincidence of leukemia and hemophilia led to a
challenge in developing a treatment strategy. Thrombocy-
topenia, a complication associated with chemotherapy,
can exacerbate bleeding diathesis in severe hemophilia
patients and may result in life-threatening bleeding, there-
fore the threshold for platelet transfusion is kept high. The
use of blood products including plasma-derived Factor
VIII and platelets may be associated with a risk of virus
transmission, in addition to increasing the cost of treat-
ment, leading to a financial burden on the patient and his
family.
Conclusion
The coincidence of hemophilia and leukemia is rare, more
so in pediatric age group. This is the sixth case in the liter-
ature, which is required to be mentioned for its rarity. The
mechanism leading to the combination of these diseases
needs further investigation. While both hemophilia and
leukemia are severe blood diseases, proper treatment can
bring about favorable results.
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